Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Return on Capital Employed (2020 - 2025)

Historic Return on Capital Employed for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to 0.07%.

  • Mirum Pharmaceuticals' Return on Capital Employed rose 1000.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year increase of 1000.0%. This contributed to the annual value of 0.16% for FY2024, which is 1000.0% up from last year.
  • Latest data reveals that Mirum Pharmaceuticals reported Return on Capital Employed of 0.07% as of Q3 2025, which was up 1000.0% from 0.1% recorded in Q2 2025.
  • Over the past 5 years, Mirum Pharmaceuticals' Return on Capital Employed peaked at 0.07% during Q3 2025, and registered a low of 0.86% during Q3 2021.
  • In the last 5 years, Mirum Pharmaceuticals' Return on Capital Employed had a median value of 0.36% in 2023 and averaged 0.39%.
  • Per our database at Business Quant, Mirum Pharmaceuticals' Return on Capital Employed tumbled by -1800bps in 2021 and then skyrocketed by 3500bps in 2022.
  • Quarter analysis of 5 years shows Mirum Pharmaceuticals' Return on Capital Employed stood at 0.78% in 2021, then skyrocketed by 43bps to 0.45% in 2022, then soared by 56bps to 0.19% in 2023, then rose by 17bps to 0.16% in 2024, then surged by 56bps to 0.07% in 2025.
  • Its Return on Capital Employed was 0.07% in Q3 2025, compared to 0.1% in Q2 2025 and 0.14% in Q1 2025.